Jpmorgan Healthcare Leaders ETFNASDAQ:JDOC
- LAST PRICE56.66
- TODAY'S CHANGE (%)0.18 (0.31%)
- Bid / Lots42.53/ 2
- Ask / Lots70.87/ 2
- Open / Previous Close56.66 / 56.48
- Day Range
- 52 Week Range
- Volume---
- Overall Morningstar RatingNot Ratedout of 269 funds
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | JDOC |
|---|---|---|
| 03:59 ET | 0 | 56.6555 |
Daily Premium/Discount
| Date | Daily Premium/Discount |
|---|---|
| 02/05/2024 | 0.21% |
| 02/06/2024 | -0.01% |
| 02/07/2024 | 0.12% |
| 02/08/2024 | 0.07% |
| 02/09/2024 | 0.07% |
| 02/12/2024 | 0.07% |
| 02/13/2024 | 0.09% |
| 02/15/2024 | 0.10% |
| 02/16/2024 | 0.09% |
| 02/20/2024 | 0.06% |
| 02/21/2024 | 0.13% |
| 02/22/2024 | 0.07% |
| 02/23/2024 | 0.16% |
| 02/26/2024 | 0.06% |
| 02/27/2024 | 0.10% |
| 02/28/2024 | 0.00% |
| 02/29/2024 Largest Premium | 0.22% |
| 03/01/2024 | 0.17% |
| 03/04/2024 | 0.03% |
| 03/05/2024 | 0.11% |
| 03/06/2024 | 0.10% |
| 03/08/2024 | 0.12% |
| 03/11/2024 | 0.08% |
| 03/12/2024 | 0.06% |
| 03/13/2024 | 0.08% |
| 03/14/2024 | -0.01% |
| 03/15/2024 | 0.03% |
| 03/18/2024 | 0.02% |
| 03/19/2024 | 0.06% |
| 03/20/2024 | -0.01% |
| 03/21/2024 | 0.15% |
| 03/22/2024 | 0.03% |
| 03/25/2024 | -0.05% |
| 03/26/2024 | 0.09% |
| 03/27/2024 | 0.01% |
| 03/28/2024 | 0.14% |
| 04/01/2024 | -0.01% |
| 04/02/2024 | 0.06% |
| 04/03/2024 | 0.05% |
| 04/04/2024 | -0.01% |
| 04/05/2024 | 0.03% |
| 04/09/2024 Largest Discount | -0.10% |
| 04/10/2024 | -0.08% |
| 04/11/2024 | 0.04% |
| 04/12/2024 | -0.05% |
| 04/15/2024 | 0.03% |
| 04/16/2024 | -0.07% |
| 04/17/2024 | 0.08% |
| 04/18/2024 | -0.06% |
| 04/19/2024 | 0.01% |
| 04/22/2024 | 0.00% |
| 04/23/2024 | 0.00% |
| 04/24/2024 | 0.02% |
| 04/25/2024 | -0.04% |
| 04/26/2024 | 0.07% |
| 04/29/2024 | -0.05% |
| 04/30/2024 | 0.05% |
| 05/01/2024 | 0.08% |
| 05/02/2024 | -0.07% |
| US Stock | 77.0% |
|---|---|
| Non-US Stock | 21.3% |
| Cash | 1.8% |
| Convertible | 0 |
| Non-US Bond | 0 |
| Other | 0 |
| Healthcare | 98.2% |
|---|---|
| Basic Mat. | 0 |
| Communication Services | 0 |
| Consumer Cyclical | 0 |
| Consumer Defensive | 0 |
| Energy | 0 |
| Financial Serv.s | 0 |
| Industrials | 0 |
| Real Estate | 0 |
| Technology | 0 |
| Utilities | 0 |
| United States | 78.4% |
|---|---|
| Europe | 3.3% |
| Asia/Oceania | 1.6% |
| Africa | 0 |
| Latin America | 0 |
| Canada | 0 |
| Company Name sortable | Position sortable | Allocation sortable | Allocation sortable1 Month Change | Market Value sortable |
|---|---|---|---|---|
Eli Lilly and Co | Long | 9.4% | 0.00% | $660.0K |
UnitedHealth Group Inc | Long | 7.7% | 0.00% | $544.6K |
Novo Nordisk A/S Class B | Long | 5.8% | 0.00% | $407.3K |
AstraZeneca PLC | Long | 5.0% | 0.00% | $349.2K |
AbbVie Inc | Long | 4.6% | 0.00% | $323.3K |
Regeneron Pharmaceuticals Inc | Long | 4.4% | 0.00% | $310.0K |
Danaher Corp | Long | 3.4% | 0.00% | $237.2K |
The Cigna Group | Long | 2.9% | 0.00% | $206.7K |
Johnson & Johnson | Long | 2.9% | 0.00% | $202.1K |
Stryker Corp | Long | 2.7% | 0.00% | $192.8K |
Reports
Morningstar Ratings
| Time Horizon | Star Rating |
|---|---|
| Overall Rating | Not Rated |
| 3 Year Rating | Not Rated |
| 5 Year Rating | Not Rated |
| 10 Year Rating | Not Rated |
Past performance is no guarantee of future results. The ratings reflect historical risk-adjusted performance, and the overall rating is derived from a weight average of the fund's 3, 5, and 10 year (Morningstar Rating) metrics.
Style Box is calculated only using the long position holdings of the portfolio.
Best Fit Index | N/A |
|---|---|
Category | |
Sponsor | J.P. Morgan Investment Management, Inc. |
Inception | November 1, 2023 |
The investment seeks to provide long-term capital appreciation. The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market. Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
| Total Net Assets | $7.0M |
|---|---|
| Shares Out. | 125.0K |
| Net Asset Value (NAV) | $56.52 |
| Prem/Discount to NAV | -0.07% |
| P/E Ratio | 33.4 |
| Dividend Yield | 0.14% |
| Dividend per Share | 0.08 USD |
| Ex-Dividend Date | 12/19/2023 |
| Dividend Payment Date | 12/22/2023 |
| Beta | --- |
| Morningstar Investment Style | Health |
| Equity Style | Large Cap Growth |
| Credit Quality / Duration | --- |
| Actual Management Fee | 0.65% |
|---|---|
| Actual Mgmt. Expense Ratio (MER) | --- |